OBJECTIVE: In addition to the main multiple sclerosis (MS) major histocompatibility complex (MHC) risk allele (HLA DRB1*1501), investigations of the MHC have implicated several class I MHC loci (HLA A, HLA B, and HLA C) as potential independent MS susceptibility loci. Here, we evaluate the role of 3 putative protective alleles in MS: HLA A*02, HLA B*44, and HLA C*05. METHODS: Subjects include a clinic-based patient sample with a diagnosis of either MS or a clinically isolated syndrome (n = 532), compared to subjects in a bone marrow donor registry (n = 776). All subjects have 2-digit HLA data. Logistic regression was used to determine the independence of each allele's effect. We used linear regression and an additive model to test for correlation between an allele and MRI and clinical measures of disease course. RESULTS: After accounting for the effect of HLA DRB1*1501, both HLA A*02 and HLA B*44 are validated as susceptibility alleles (p(A*02) 0.00039 and p(B*44) 0.00092) and remain significantly associated with MS susceptibility in the presence of the other allele. Although A*02 is not associated with MS outcome measures, HLA B*44 demonstrates association with a better radiologic outcome both in terms of brain parenchymal fraction and T2 hyperintense lesion volume (p = 0.03 for each outcome). CONCLUSION: The MHC class I alleles HLA A*02 and HLA B*44 independently reduce susceptibility to MS, but only HLA B*44 appears to influence disease course, preserving brain volume and reducing the burden of T2 hyperintense lesions in subjects with MS.
OBJECTIVE: In addition to the main multiple sclerosis (MS) major histocompatibility complex (MHC) risk allele (HLA DRB1*1501), investigations of the MHC have implicated several class I MHC loci (HLA A, HLA B, and HLA C) as potential independent MS susceptibility loci. Here, we evaluate the role of 3 putative protective alleles in MS: HLA A*02, HLA B*44, and HLA C*05. METHODS: Subjects include a clinic-based patient sample with a diagnosis of either MS or a clinically isolated syndrome (n = 532), compared to subjects in a bone marrow donor registry (n = 776). All subjects have 2-digit HLA data. Logistic regression was used to determine the independence of each allele's effect. We used linear regression and an additive model to test for correlation between an allele and MRI and clinical measures of disease course. RESULTS: After accounting for the effect of HLA DRB1*1501, both HLA A*02 and HLA B*44 are validated as susceptibility alleles (p(A*02) 0.00039 and p(B*44) 0.00092) and remain significantly associated with MS susceptibility in the presence of the other allele. Although A*02 is not associated with MS outcome measures, HLA B*44 demonstrates association with a better radiologic outcome both in terms of brain parenchymal fraction and T2 hyperintense lesion volume (p = 0.03 for each outcome). CONCLUSION: The MHC class I alleles HLA A*02 and HLA B*44 independently reduce susceptibility to MS, but only HLA B*44 appears to influence disease course, preserving brain volume and reducing the burden of T2 hyperintense lesions in subjects with MS.
Authors: Philip L De Jager; Elizabeth Rossin; Saumyadipta Pyne; Pablo Tamayo; Linda Ottoboni; Vissia Viglietta; Mira Weiner; Dulce Soler; Elena Izmailova; Lauren Faron-Yowe; Carmeline O'Brien; Sam Freeman; Susana Granados; Alex Parker; Ronenn Roubenoff; Jill P Mesirov; Samia J Khoury; David A Hafler; Howard L Weiner Journal: Brain Date: 2008-06-21 Impact factor: 13.501
Authors: Michael J Chao; Martin C N M Barnardo; Matthew R Lincoln; Sreeram V Ramagopalan; Blanca M Herrera; David A Dyment; Alexandre Montpetit; A Dessa Sadovnick; Julian C Knight; George C Ebers Journal: Proc Natl Acad Sci U S A Date: 2008-09-02 Impact factor: 11.205
Authors: C Smestad; B Brynedal; G Jonasdottir; A R Lorentzen; T Masterman; E Akesson; A Spurkland; B A Lie; J Palmgren; E G Celius; J Hillert; H F Harbo Journal: Eur J Neurol Date: 2007-08 Impact factor: 6.089
Authors: R K Burfoot; C J Jensen; J Field; J Stankovich; M D Varney; L J Johnson; H Butzkueven; D Booth; M Bahlo; B D Tait; B V Taylor; T P Speed; R Heard; G J Stewart; S J Foote; T J Kilpatrick; J P Rubio Journal: Tissue Antigens Date: 2007-10-30
Authors: Sergio E Baranzini; Joanne Wang; Rachel A Gibson; Nicholas Galwey; Yvonne Naegelin; Frederik Barkhof; Ernst-Wilhelm Radue; Raija L P Lindberg; Bernard M G Uitdehaag; Michael R Johnson; Aspasia Angelakopoulou; Leslie Hall; Jill C Richardson; Rab K Prinjha; Achim Gass; Jeroen J G Geurts; Jolijn Kragt; Madeleine Sombekke; Hugo Vrenken; Pamela Qualley; Robin R Lincoln; Refujia Gomez; Stacy J Caillier; Michaela F George; Hourieh Mousavi; Rosa Guerrero; Darin T Okuda; Bruce A C Cree; Ari J Green; Emmanuelle Waubant; Douglas S Goodin; Daniel Pelletier; Paul M Matthews; Stephen L Hauser; Ludwig Kappos; Chris H Polman; Jorge R Oksenberg Journal: Hum Mol Genet Date: 2008-11-14 Impact factor: 6.150
Authors: D T Okuda; R Srinivasan; J R Oksenberg; D S Goodin; S E Baranzini; A Beheshtian; E Waubant; S S Zamvil; D Leppert; P Qualley; R Lincoln; R Gomez; S Caillier; M George; J Wang; S J Nelson; B A C Cree; S L Hauser; D Pelletier Journal: Brain Date: 2008-11-20 Impact factor: 13.501
Authors: Sreeram V Ramagopalan; Andrew P Morris; David A Dyment; Blanca M Herrera; Gabriele C DeLuca; Matthew R Lincoln; Sarah M Orton; Michael J Chao; A Dessa Sadovnick; George C Ebers Journal: PLoS Genet Date: 2007-07-20 Impact factor: 5.917
Authors: Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert Journal: PLoS One Date: 2007-07-25 Impact factor: 3.240
Authors: Noriko Isobe; Anisha Keshavan; Pierre-Antoine Gourraud; Alyssa H Zhu; Esha Datta; Regina Schlaeger; Stacy J Caillier; Adam Santaniello; Antoine Lizée; Daniel S Himmelstein; Sergio E Baranzini; Jill Hollenbach; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg; Roland G Henry Journal: JAMA Neurol Date: 2016-07-01 Impact factor: 18.302
Authors: Riley Bove; Tanuja Chitnis; Bruce Ac Cree; Mar Tintoré; Yvonne Naegelin; Bernard Mj Uitdehaag; Ludwig Kappos; Samia J Khoury; Xavier Montalban; Stephen L Hauser; Howard L Weiner Journal: Mult Scler Date: 2017-08-29 Impact factor: 6.312
Authors: Lisa E Creary; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Jorge R Oksenberg; Marcelo A Fernández-Viňa Journal: Mult Scler Date: 2018-04-23 Impact factor: 6.312